» Authors » Tae Kwann Park

Tae Kwann Park

Explore the profile of Tae Kwann Park including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 67
Citations 643
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hwang S, Jeon S, Yoon J, Woo S, Joo K, Choi Y, et al.
Am J Ophthalmol . 2025 Mar; PMID: 40057012
Purpose: To describe in detail the genetic profile, clinical features, and genotype-phenotype correlation of retinitis pigmentosa GTPase regulator (RPGR)-associated X-linked retinitis pigmentosa (RP) in Koreans. Design: A retrospective multicenter case...
2.
Kim C, Park J, Choi Y, Jun H, Chung J, Park T, et al.
Front Endocrinol (Lausanne) . 2024 Sep; 15:1420024. PMID: 39280007
Introduction: Bruton's tyrosine kinase (BTK) and interleukin (IL)-2 Inducible T-cell Kinase (ITK) inhibitors have anti-inflammatory properties. We investigated the therapeutic effect of ibrutinib, an orally bioavailable BTK/ITK inhibitor, in a...
3.
Han J, Chang H, Park S, Yang J, Kim Y, Kim J, et al.
Int J Mol Sci . 2024 Aug; 25(15). PMID: 39125773
X-linked juvenile retinoschisis (XLRS) is a hereditary retinal degeneration affecting young males caused by mutations in the retinoschisin () gene. We generated human induced pluripotent stem cells (hiPSCs) from XLRS...
4.
Park H, Bang J, Jung W, Yang J, Shin H, Son J, et al.
Int J Mol Sci . 2024 Aug; 25(15). PMID: 39125582
Human retinal organoids (ROs) have emerged as valuable tools for studying retinal development, modeling human retinal diseases, and screening drugs. However, their application is limited primarily due to time-intensive generation,...
5.
Im S, Han J, Park E, Bang J, Shin H, Chang H, et al.
PLoS One . 2023 Oct; 18(10):e0293237. PMID: 37847723
[This corrects the article DOI: 10.1371/journal.pone.0269937.].
6.
Han J, Chang H, Yang J, Choi H, Park H, Jun H, et al.
Int J Mol Sci . 2023 Aug; 24(15). PMID: 37569444
Increasing evidence suggests that exosomes are involved in retinal cell degeneration, including their insufficient release; hence, they have become important indicators of retinopathies. The exosomal microRNA (miRNA), in particular, play...
7.
Kim J, Lee S, Park T, Sun H, Kim H, Cho I, et al.
Korean J Ophthalmol . 2023 Aug; 37(5):365-372. PMID: 37562440
Purpose: To compare short-term efficacy and safety of intravitreal brolucizumab injection with aflibercept in treatment-naive neovascular age-related macular degeneration (nAMD) patients. Methods: A total of 59 eyes from 59 treatment-naive...
8.
Han J, Joo K, Kim U, Woo S, Lee E, Lee J, et al.
Korean J Ophthalmol . 2023 Mar; 37(2):166-186. PMID: 36950921
Mutations in the RPE65 gene, associated with Leber congenital amaurosis, early-onset severe retinal dystrophy, and retinitis pigmentosa, gained growing attention since gene therapy for patients with RPE65-associated retinal dystrophy is...
9.
Im S, Han J, Park E, Bang J, Shin H, Chang H, et al.
PLoS One . 2022 Jun; 17(6):e0269937. PMID: 35696413
Choroidal neovascularization (CNV) is a defining characteristic feature of neovascular age-related macular degeneration (nAMD) that frequently results in irreversible vision loss. The current strategies for the treatment of nAMD are...
10.
Ro J, Moon J, Park T, Lee S
Sci Rep . 2022 Mar; 12(1):3423. PMID: 35232992
Various non-intraocular pressure factors have been identified as possible risk factors for open-angle glaucoma (OAG). However, there is still controversy around the association between OAG and chronic kidney disease (CKD)....